136 related articles for article (PubMed ID: 1868115)
21. A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation.
Wester HJ; Hamacher K; Stöcklin G
Nucl Med Biol; 1996 Apr; 23(3):365-72. PubMed ID: 8782249
[TBL] [Abstract][Full Text] [Related]
22. N-(m-[125I]iodophenyl)maleimide: an agent for high yield radiolabeling of antibodies.
Khawli LA; van den Abbeele AD; Kassis AI
Int J Rad Appl Instrum B; 1992 Apr; 19(3):289-95. PubMed ID: 1629018
[TBL] [Abstract][Full Text] [Related]
23. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
[TBL] [Abstract][Full Text] [Related]
24. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
[TBL] [Abstract][Full Text] [Related]
25. An antibody-desferrioxamine conjugate labelled with 67Ga.
Ward MC; Roberts KR; Babich JW; Bukhari MA; Coghlan G; Westwood JH; McCready VR; Ott RJ
Int J Rad Appl Instrum B; 1986; 13(5):505-7. PubMed ID: 3818312
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
27. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
[TBL] [Abstract][Full Text] [Related]
28. Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part II. Comparison of immunoreactivity and biodistribution of monoclonal antibodies labeled with the 67Ga-chelate or with 131I.
Matzku S; Schuhmacher J; Kirchgessner H; Brüggen J
Eur J Nucl Med; 1986; 12(8):405-12. PubMed ID: 3792375
[TBL] [Abstract][Full Text] [Related]
29. Ga-labeling of immunoglobulin G with high specific radioactivity.
Furukawa T; Fujibayashi Y; Fukunaga M; Yokoyama A
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2285-6. PubMed ID: 2279293
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
Hashmi M; Rosebrough SF
Drug Metab Dispos; 1995 Dec; 23(12):1362-7. PubMed ID: 8689944
[TBL] [Abstract][Full Text] [Related]
31. Biological characterisation of [67Ga] or [68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors.
Stolz B; Smith-Jones PM; Albert R; Reist H; Mäcke H; Bruns C
Horm Metab Res; 1994 Oct; 26(10):453-9. PubMed ID: 7851867
[TBL] [Abstract][Full Text] [Related]
32.
Ioppolo JA; Caldwell D; Beiraghi O; Llano L; Blacker M; Valliant JF; Berti PJ
Nucl Med Biol; 2017 Sep; 52():32-41. PubMed ID: 28602965
[TBL] [Abstract][Full Text] [Related]
33. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
[TBL] [Abstract][Full Text] [Related]
34. A 125I-radiolabel transfer crosslinking reagent with a novel cleavable group.
Schwartz MA
Anal Biochem; 1985 Aug; 149(1):142-52. PubMed ID: 4073473
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of bifunctional antibodies for immunoassays.
DeSilva BS; Wilson GS
Methods; 2000 Sep; 22(1):33-43. PubMed ID: 11020315
[TBL] [Abstract][Full Text] [Related]
36. Positive imaging of venous thrombi and thromboemboli with Ga-67 DFO-DAS-fibrinogen.
Yamamoto K; Senda M; Fujita T; Kumada K; Fukui K; Yonekura Y; Yokoyama A; Torizuka K
Eur J Nucl Med; 1988; 14(2):60-4. PubMed ID: 3391213
[TBL] [Abstract][Full Text] [Related]
37. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
38. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
[TBL] [Abstract][Full Text] [Related]
39. Preparation and biological evaluation of radiolabelled antibodies with selected carbohydrate modifications.
Qi P; Sykes TR; Koganty RR; Selvaraj S; Noujaim AA
Nucl Med Biol; 1993 May; 20(4):453-9. PubMed ID: 8504287
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.
Kemp JD; Cardillo T; Stewart BC; Kehrberg E; Weiner G; Hedlund B; Naumann PW
Cancer Res; 1995 Sep; 55(17):3817-24. PubMed ID: 7641199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
